Brazil is at risk of becoming the 'incubator' of the nCoV strain
Amidst many Brazilians still partying, an official warned that "there are no ICU beds for everyone's parents, aunts, sons, or girlfriends".
continue reading
Biden: 'Safe Covid-19 Vaccine'
Biden says companies spend a lot of time testing the safety of Covid-19 vaccines and asserting that the products are safe.
continue reading
The US does not give vaccines to the world when people are not fully vaccinated
The US government is not expected to fund any Covid-19 vaccine until most of the population has been vaccinated.
continue reading
Africa defends AstraZeneca's Covid-19 vaccine
The African Union's disease control agency confirmed that vacicne Covid-19 AstraZeneca was not abandoned, although the effect was significantly reduced with the South African nCoV strain.
continue reading
China is ready to supply vaccines to Central and Eastern Europe
President Xi Jinping announced that China is ready to supply more vaccines and strengthen trade relations with Central and Eastern European countries.
continue reading
The EU is in a state of mind before vaccine Covid-19 Russia, China
On February 4, French President Macron admitted China's efforts to develop the Covid-19 vaccine were "an obvious diplomatic success" that "made them" a little humiliated ".
continue reading
Laos receives 300,000 doses of Covid-19 vaccine from China
Laos received a batch of vaccine produced by the Chinese company Sinopharm, which is starting to inject medical staff and frontline forces.
continue reading
Being vaccinated with 'lightning speed', Israel still struggled with Covid-19
Despite vaccinating more than half of the population, outpacing other countries, Israel still recorded 1,400 Covid-19 deaths in January.
continue reading
The risk of rich water 'acquiring' the Covid-19 vaccine
More than 80 million doses of Covid-19 vaccine have been distributed globally, but only 55 of them reach people in a low-income country.
continue reading
The US develops a vaccine to deal with a new CoV strain
The US company Novavax developed the Covid-19 vaccine that was 89.3 percent effective in the Phase Three trial in the UK, but at a lower rate with the South African strain.
continue reading
